Nadine Wong

Articles From This Author

PERSONAL FINANCE

IMCL

By Nadine Wong

Jan 24, 2002 7:50 AM EST

PERSONAL FINANCE

DNA AMGN GENZ

By Nadine Wong

Jan 17, 2002 7:27 AM EST

PERSONAL FINANCE

IMCL BMY

By Nadine Wong

Jan 10, 2002 9:55 AM EST

PERSONAL FINANCE

IMCL BMY

By Nadine Wong

Jan 3, 2002 8:03 AM EST

PERSONAL FINANCE

SEPR SGP PFE

By Nadine Wong

Dec 27, 2001 7:58 AM EST

PERSONAL FINANCE

AMGN IMNX

By Nadine Wong

Dec 20, 2001 9:24 AM EST

PERSONAL FINANCE

PDLI

By Nadine Wong

Dec 13, 2001 8:34 AM EST

PERSONAL FINANCE

MEDI AVIR

By Nadine Wong

Dec 6, 2001 8:02 AM EST

PERSONAL FINANCE

STEM GERN ASTM

By Nadine Wong

Nov 29, 2001 7:55 AM EST

PERSONAL FINANCE

By Nadine Wong

Nov 21, 2001 7:31 AM EST

PERSONAL FINANCE

IMNX AMGN

By Nadine Wong

Nov 15, 2001 7:10 AM EST

PERSONAL FINANCE

PDLI

By Nadine Wong

Nov 8, 2001 8:39 AM EST

PERSONAL FINANCE

CIPH

By Nadine Wong

Oct 31, 2001 2:43 PM EST

PERSONAL FINANCE

GILD

By Nadine Wong

Oct 24, 2001 2:31 PM EDT

PERSONAL FINANCE

CPHD BDAL

By Nadine Wong

Oct 17, 2001 12:43 PM EDT

PERSONAL FINANCE

CORR

By Nadine Wong

Oct 10, 2001 12:54 PM EDT

PERSONAL FINANCE

GILD IMNX ICOS

By Nadine Wong

Oct 3, 2001 1:49 PM EDT

PERSONAL FINANCE

CPHD BDAL

By Nadine Wong

Sep 26, 2001 10:44 AM EDT

PERSONAL FINANCE

NVS LLY SGP

By Nadine Wong

Sep 17, 2001 9:39 AM EDT

PERSONAL FINANCE

AMGN DNA

By Nadine Wong

Sep 5, 2001 2:57 PM EDT

PERSONAL FINANCE

GILD

By Nadine Wong

Aug 29, 2001 2:46 PM EDT

Nadine Wong

Articles From This Author

How to Evaluate Biotechs That Aren't Profitable Yet

This Earnings Season Could Be a Good One for Biotechs

Don't Write Off ImClone Just Yet

ImClone's Potential Could Be Worth the Risk

Biotech's Prognosis Improves at Year-End

The Amgen-Immunex Deal Is the Right Prescription

Protein Design Labs Is Still Worth Owning

Who Wins, Who Loses in the MedImmune-Aviron Deal

How to Play Stem-Cell Research Stocks

Some Biotech Mutual Funds Worth Considering

How to Know if the Price Is Right on a Biotech Stock

Protein Design Labs' Pipeline Shows Some Promising New Drugs

Ciphergen Ready to Capitalize on New Protein Research

Think About Taking Profits in Gilead Sciences

These Bioterrorism Stocks Aren't Worth Playing Anymore

Keep Your Eye On COR Therapeutics

Some Biotech Stocks Set to Get Booster Shots

Biotech Companies Look to Combat Terrorism

Biotechs and Big Pharma: How to Invest

Potential Winners in the Biotech Space

Gilead Sciences Pins Its Hopes on HIV Drug